Add to favorite
Subscribe to our Newsletters Subscribe to our Newsletters Get Daily Updates RSS

Using a Thrombolytic Drug against Coronavirus Suggested in Russia
29.04.2020 15:16
Using a Thrombolytic Drug against Coronavirus Suggested in Russia

An interagency task force to fight coronavirus at the Siberian Branch of the Russian Academy of Sciences examined the first oral thrombolytic drug, Trombovazim, for use against the effects of COVID. It was reported by Olga Dorokhova, the executive secretary of the task force at the SB RAS.

      She noted that one of the main causes of high mortality of COVID-19 is associated pneumonia caused by coronavirus, and aggravating its course. In the process, a blood clot of fibrin protein is generated in the lungs and blood vessels.

      "That said, there is a new generation fibrinolytic in Russia - Trombovazim. Today, Trombovazim can be considered a target drug," - Olga Dorokhova said.

      Thrombovazim is able to gently inhibit both the formation of fibrin clots and thrombosis in capillaries.

Author: Vera Ivanova

Tags: Russian Medicine COVID    

Next Previous

You might also find interesting:

Comment on our site

RSS   twitter      submit

Fire  Russian Actresses  Novodevichy Convent   Russian folk tales  Yury Roerich  Russian aviation  Exhibitions in Moscow  Aeroflot  Russian academy of sciences  Tickets for Concerts  Norilsk Nickel  Russian exhibitions  Central Bank  Art Criticism  Blue Rose  Virtual Tours   FIFA world cup 2018 tickets  Sheremetyevo  easyJet   Mercedes-Benz Fashion Week Russia  External Debt  Russian Cinema  Russian Internet  Russian economy  contests  Great Patriotic War  Cars  Pertsov's House  Russian science  Russian Animation  Russian tourism  Kuznetsk Basin  Silver Patination  Toilets  Meteorites  Russian Composers  St. Petersburg  Solovki  Moscow  AvtoVAZ   invest  Moscow Institute of Steel and Alloys  curious  physics  Biological Age  Moscow restaurants  Russian winter  Russian scientists  Zima  Russian business 

Travel Blogs
Top Traveling Sites